Theranova, L.L.C.
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Theranova, L.L.C. sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).
Theranova, L.L.C.: 11 sponsored US clinical trials, 1 recruiting.
Theranova, L.L.C. sponsors 11 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 8 completed. The most-studied condition in this pipeline is Alcohol Use Disorder, with 2 trials.
Top-decile sponsor footprint
Theranova, L.L.C. ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
11 total, page 1 of 1
Airway Data Collection With the Entarik Feeding Tube System
NCT06760572
Pilot Research on Opioid Use Disorder
NCT04244227
EMPOWER AUD Pivotal Trial
NCT05948605
Evaluation of the TheraNova Neuromodulation System to Provide Durable Relief of Overactive Bladder Symptoms
NCT05162833
Evaluation of the TheraNova Neuromodulation System for the Treatment of Overactive Bladder Symptoms
NCT04758247
Empower Neuromodulation System - Pilot Study for Anxiety Treatment
NCT04901481
Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain
NCT04166045
Pilot Evaluation of the Empower Neuromodulation System in AUD Patients
NCT03983317
Treatment Parameters for the Empower Neuromodulation System (ENS)
NCT03807544
Posterior Tibial Nerve Stimulation's Effectiveness in UI Frequency in Overactive Patients in Home
NCT03595215
Wearable Vibration Device to Prevent Bone Loss in Postmenopausal Women--Aim 2
NCT03688282
Therapeutic Areas
What is open in the Theranova, L.L.C. pipeline
1 recruiting of 11 indexed (9% open); 8 completed (73%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Alcohol Use Disorder (2 trials), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Theranova, L.L.C.: open-pipeline peers nationwide
Peers matched on 11 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
Theranova, L.L.C. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 11 trials (± recruiting share)
- Aderans Research Institute · 11 trials · 0% recruiting
- Aegerion Pharmaceuticals · 11 trials · 0% recruiting
- Allena Pharmaceuticals · 11 trials · 0% recruiting
- AOBiome · 11 trials · 0% recruiting
Sponsors near 9% open enrollment (± trial volume)
- Alkermes · 9% recruiting · 66 trials
- DBV Technologies · 9% recruiting · 11 trials
- Florida Gulf Coast University · 9% recruiting · 11 trials
- Genfit · 9% recruiting · 11 trials
Related
What to do with this Theranova, L.L.C. page
11 registered trials is a research-attention snapshot, not an endorsement of Theranova, L.L.C. or any single study.
- 1 of Theranova, L.L.C.'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alcohol Use Disorder is the condition Theranova, L.L.C. studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcohol Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Theranova, L.L.C. pipeline card: 11 registered trials from official public datasets.Report a data error.